Cargando…
A case of steroid‐resistant cystitis as an immune‐related adverse event during treatment with nivolumab for lung cancer, which was successfully treated with infliximab
INTRODUCTION: Immune checkpoint inhibitors are widely used in various cancers as a standard treatment. However, while various immune‐related adverse events related to immune checkpoint inhibitors have been reported, there are few reports of lower urinary tract symptoms. CASE PRESENTATION: The patien...
Autores principales: | Fukunaga, Hiroyuki, Sumii, Kenta, Kawamura, Shun, Okuno, Masato, Taguchi, Isao, Kawabata, Gaku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626353/ https://www.ncbi.nlm.nih.gov/pubmed/36341187 http://dx.doi.org/10.1002/iju5.12532 |
Ejemplares similares
-
Editorial Comment to A case of steroid‐resistant cystitis as an immune‐related adverse event during treatment with nivolumab for lung cancer, which was successfully treated with infliximab
por: Yuasa, Takeshi
Publicado: (2022) -
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
por: Nassri, Ammar B, et al.
Publicado: (2019) -
The Use of CT-Guided Marking for the Laparoscopic Resection of a Solitary Retroperitoneal Metastasis of Colon Cancer
por: Ueki, Hideto, et al.
Publicado: (2018) -
Emphysematous Cystitis Occurred in the Case Treated with Steroid for Autoimmune Hepatitis
por: Yoshino, Tateki, et al.
Publicado: (2013) -
Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study
por: Kadokawa, Yukio, et al.
Publicado: (2021)